Story

AMD Joins Trillion-Dollar Club as AI Bets Fuel Weekly Stock Moves

ENTHMSVIIDZHZH-TWJAKOHI
Sep 25, 20262 min read
AMD Joins Trillion-Dollar Club as AI Bets Fuel Weekly Stock Moves

Summary

Advanced Micro Devices crossed a $1 trillion market capitalization this week, while Meta and Moderna also saw significant gains. Oracle shares declined following a report on potential delays at a key data center project.

Text size
Background

A surge in investor enthusiasm for artificial intelligence propelled several major technology stocks higher this week, most notably pushing chipmaker Advanced Micro Devices into the elite trillion-dollar market capitalization club. While AI and positive clinical data fueled significant gains for some, concerns over a large-scale data center project weighed on shares of Oracle.

AI Enthusiasm Lifts Tech Giants

Advanced Micro Devices (AMD) saw its shares climb 15.2% over the week, pushing its market valuation past the $1 trillion mark. According to Investing.com, AMD is now the fourth U.S. semiconductor company to reach this milestone, reflecting investors' growing confidence in its expanding role in the AI computing sector.

Meta Platforms (META) also benefited from AI-related news, with its stock rising over 9% for the week. The gains followed the company's Meta Connect event, where it showcased a series of AI advancements. Analysts at Mizuho reiterated an Outperform rating on the stock, noting that Meta is successfully pivoting toward a more AI-centric strategy.

Deals and Data Boost Akamai, Moderna

Shares of Akamai Technologies (AKAM) rose 7.5% after the company announced a significantly expanded partnership with AI firm Anthropic. The deal includes $11.6 billion in contractual commitments over seven years, prompting analysts at D.A. Davidson to suggest that future earnings estimates for Akamai could move substantially higher.

Sample IUX Markets – In-articleAd

Moderna (MRNA) was the week's standout performer, with its stock soaring 25.7%. The rally was driven by continued optimism for its mRNA technology beyond COVID-19 vaccines, following positive Phase 3 data for its personalized cancer vaccine developed in partnership with Merck.

Oracle Slips on Data Center Concerns

In contrast to the week's winners, Oracle (ORCL) shares fell 8.2%. The decline followed a Bloomberg report that the company had issued a force majeure notice to the developer of its New Mexico data center, seeking to suspend payments if the facility misses its planned 2028 opening.

However, an analyst at Stifel noted that the move may be a "precautionary preservation of rights rather than a formal admission of a delay." According to the analyst note, Oracle has confirmed that the project remains on schedule, with construction approximately 26% complete.

Read next

More on Stocks
Back to latest news

LATEST